Breaking News

Vector BioMed, CIRM Partner on Lentiviral Vector Manufacture

Partnership will leverage the VBM teams' experience in design and manufacture of preclinical and GMP-grade lentiviral vectors.

Vector BioMed (VBM), a biomanufacturing company specializing in lentiviral vectors, entered into an agreement with the California Institute for Regenerative Medicine (CIRM) to be a lentiviral vector manufacturer within CIRM’s Industry Alliance Program (IAP). With $5.5 billion in funding from the state of California, CIRM is involved in the development and funding of regenerative medicine clinical trials focused on cell-based and gene therapies. VBM helps design and manufacture high-qual...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters